Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.
| Image |  |
|---|---|
| Description | scientific article published on 2 March 2010 |
| Author/s |
author: Christoph Gasche |
| Publication date | March 2, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |